rs61736451

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001001331.4(ATP2B2):​c.1891G>A​(p.Val631Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00943 in 1,614,226 control chromosomes in the GnomAD database, including 143 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0079 ( 17 hom., cov: 33)
Exomes 𝑓: 0.0096 ( 126 hom. )

Consequence

ATP2B2
NM_001001331.4 missense

Scores

1
5
11

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 2.19

Publications

20 publications found
Variant links:
Genes affected
ATP2B2 (HGNC:815): (ATPase plasma membrane Ca2+ transporting 2) The protein encoded by this gene belongs to the family of P-type primary ion transport ATPases characterized by the formation of an aspartyl phosphate intermediate during the reaction cycle. These enzymes remove bivalent calcium ions from eukaryotic cells against very large concentration gradients and play a critical role in intracellular calcium homeostasis. The mammalian plasma membrane calcium ATPase isoforms are encoded by at least four separate genes and the diversity of these enzymes is further increased by alternative splicing of transcripts. The expression of different isoforms and splice variants is regulated in a developmental, tissue- and cell type-specific manner, suggesting that these pumps are functionally adapted to the physiological needs of particular cells and tissues. This gene encodes the plasma membrane calcium ATPase isoform 2. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
ATP2B2 Gene-Disease associations (from GenCC):
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • hearing loss, autosomal dominant 82
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • neurodevelopmental disorder
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.00996235).
BP6
Variant 3-10359892-C-T is Benign according to our data. Variant chr3-10359892-C-T is described in ClinVar as Benign. ClinVar VariationId is 17801.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00788 (1200/152356) while in subpopulation AMR AF = 0.028 (428/15306). AF 95% confidence interval is 0.0258. There are 17 homozygotes in GnomAd4. There are 604 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 1200 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001001331.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATP2B2
NM_001001331.4
MANE Select
c.1891G>Ap.Val631Met
missense
Exon 13 of 23NP_001001331.1Q01814-1
ATP2B2
NM_001438646.1
c.1798G>Ap.Val600Met
missense
Exon 11 of 21NP_001425575.1
ATP2B2
NM_001353564.1
c.1756G>Ap.Val586Met
missense
Exon 11 of 21NP_001340493.1Q01814-6

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATP2B2
ENST00000360273.7
TSL:5 MANE Select
c.1891G>Ap.Val631Met
missense
Exon 13 of 23ENSP00000353414.2Q01814-1
ATP2B2
ENST00000452124.2
TSL:1
c.1798G>Ap.Val600Met
missense
Exon 10 of 20ENSP00000414854.2Q01814-8
ATP2B2
ENST00000397077.6
TSL:1
c.1756G>Ap.Val586Met
missense
Exon 10 of 20ENSP00000380267.1Q01814-6

Frequencies

GnomAD3 genomes
AF:
0.00784
AC:
1193
AN:
152238
Hom.:
14
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00289
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.0274
Gnomad ASJ
AF:
0.000865
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00414
Gnomad FIN
AF:
0.00122
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00883
Gnomad OTH
AF:
0.00716
GnomAD2 exomes
AF:
0.0115
AC:
2877
AN:
250766
AF XY:
0.0104
show subpopulations
Gnomad AFR exome
AF:
0.00252
Gnomad AMR exome
AF:
0.0477
Gnomad ASJ exome
AF:
0.0000993
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.00171
Gnomad NFE exome
AF:
0.00840
Gnomad OTH exome
AF:
0.0103
GnomAD4 exome
AF:
0.00960
AC:
14027
AN:
1461870
Hom.:
126
Cov.:
31
AF XY:
0.00926
AC XY:
6731
AN XY:
727238
show subpopulations
African (AFR)
AF:
0.00164
AC:
55
AN:
33480
American (AMR)
AF:
0.0457
AC:
2043
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.000306
AC:
8
AN:
26136
East Asian (EAS)
AF:
0.000151
AC:
6
AN:
39700
South Asian (SAS)
AF:
0.00391
AC:
337
AN:
86256
European-Finnish (FIN)
AF:
0.00125
AC:
67
AN:
53410
Middle Eastern (MID)
AF:
0.00364
AC:
21
AN:
5768
European-Non Finnish (NFE)
AF:
0.00989
AC:
10999
AN:
1112004
Other (OTH)
AF:
0.00813
AC:
491
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
880
1761
2641
3522
4402
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
446
892
1338
1784
2230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00788
AC:
1200
AN:
152356
Hom.:
17
Cov.:
33
AF XY:
0.00811
AC XY:
604
AN XY:
74500
show subpopulations
African (AFR)
AF:
0.00289
AC:
120
AN:
41586
American (AMR)
AF:
0.0280
AC:
428
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.000865
AC:
3
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00414
AC:
20
AN:
4830
European-Finnish (FIN)
AF:
0.00122
AC:
13
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00882
AC:
600
AN:
68030
Other (OTH)
AF:
0.00709
AC:
15
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
63
125
188
250
313
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00804
Hom.:
13
Bravo
AF:
0.00967
TwinsUK
AF:
0.00863
AC:
32
ALSPAC
AF:
0.0101
AC:
39
ESP6500AA
AF:
0.00159
AC:
7
ESP6500EA
AF:
0.00721
AC:
62
ExAC
AF:
0.00881
AC:
1069
Asia WGS
AF:
0.00260
AC:
9
AN:
3478
EpiCase
AF:
0.00938
EpiControl
AF:
0.00717

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not provided (3)
-
-
1
Agenesis of the corpus callosum with peripheral neuropathy (1)
-
-
1
ATP2B2-related disorder (1)
-
-
1
Deafness, autosomal recessive 12, modifier of (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.32
BayesDel_addAF
Benign
-0.28
T
BayesDel_noAF
Benign
-0.15
CADD
Benign
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.27
T
Eigen
Uncertain
0.20
Eigen_PC
Benign
0.22
FATHMM_MKL
Uncertain
0.80
D
LIST_S2
Uncertain
0.89
D
MetaRNN
Benign
0.010
T
MetaSVM
Benign
-0.45
T
MutationAssessor
Benign
1.6
L
PhyloP100
2.2
PrimateAI
Pathogenic
0.80
T
PROVEAN
Benign
-0.86
N
REVEL
Uncertain
0.34
Sift
Benign
0.24
T
Sift4G
Benign
0.16
T
Polyphen
0.85
P
Vest4
0.40
MPC
1.8
ClinPred
0.012
T
GERP RS
4.9
Varity_R
0.17
gMVP
0.83
Mutation Taster
=78/22
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61736451; hg19: chr3-10401576; COSMIC: COSV108189186; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.